Standout Papers

Development of potent monoclonal antibody auristatin conjugates for cancer therapy 2003 2026 2010 2018 888
  1. Development of potent monoclonal antibody auristatin conjugates for cancer therapy (2003)
    Svetlana O. Doronina, Brian E. Toki et al. Nature Biotechnology
  2. Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate (2004)
    Kevin J. Hamblett, Peter D. Senter et al. Clinical Cancer Research
  3. Arming antibodies: prospects and challenges for immunoconjugates (2005)
    Anna M. Wu, Peter D. Senter Nature Biotechnology
  4. cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity (2003)
    Joseph A. Francisco, Charles G. Cerveny et al. Blood
  5. Antibody-Drug Conjugates in Cancer Therapy (2012)
    Eric L. Sievers, Peter D. Senter Annual Review of Medicine
  6. The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma (2012)
    Peter D. Senter, Eric L. Sievers Nature Biotechnology
  7. Antibody–drug conjugates: targeted drug delivery for cancer (2010)
    Stephen C. Alley, Nicole M. Okeley et al. Current Opinion in Chemical Biology
  8. Antibody–drug conjugates come of age in oncology (2023)
    Charles Dumontet, Janice M. Reichert et al. Nature Reviews Drug Discovery
  9. Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index (2015)
    Robert P. Lyon, Tim D. Bovee et al. Nature Biotechnology
  10. Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates (2014)
    Robert P. Lyon, Jocelyn R. Setter et al. Nature Biotechnology

Immediate Impact

22 by Nobel laureates 14 from Science/Nature 110 standout
Sub-graph 1 of 18

Citing Papers

Principles and therapeutic applications of adaptive immunity
2024 Standout
Nanomedicine Tumor Targeting
2024 Standout
48 intermediate papers

Works of Peter D. Senter being referenced

Antibody-Drug Conjugates in Cancer Therapy
2012 Standout
Antibody drug-conjugates targeting the tumor vasculature
2009
and 50 more

Author Peers

Author Last Decade Papers Cites
Peter D. Senter 8142 7638 6546 177 14.8k
Dario Neri 9862 7248 15036 524 24.9k
Mark X. Sliwkowski 9663 14288 9750 110 21.5k
Joyce Taylor‐Papadimitriou 5567 4454 12186 243 17.9k
Vladimir Tolmachev 9183 4834 3964 387 11.6k
Ralph A. Reisfeld 3188 5154 7933 217 16.5k
John M. Lambert 3803 3924 3336 127 8.0k
David Colcher 6580 3140 3884 206 9.8k
Louis M. Weiner 4941 8335 6465 254 16.2k
Alain Beck 6944 2857 8280 209 12.4k
Janice M. Reichert 5012 2313 5389 92 9.4k

All Works

Loading papers...

Rankless by CCL
2026